Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients

BACKGROUND: As a common cancer-related death worldwide, pancreatic adenocarcinoma (PAAD) has significantly increased mortality in recent years. In recent years, tumor mutation burden (TMB) has been regarded as the most popular biomarker for PAAD immunotherapy. However, it remains unclear which gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yili, Liu, Jinsong, Zhu, Xiaole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597037/
https://www.ncbi.nlm.nih.gov/pubmed/36312851
http://dx.doi.org/10.1177/20552076221133699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597037/
https://www.ncbi.nlm.nih.gov/pubmed/36312851
http://dx.doi.org/10.1177/20552076221133699

Ejemplares similares